Skip to main content
Equibles

Deep Track Capital, LP

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1856083 GREENWICH, CT
Back to VRDN Full portfolio

Position in VRDN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$65,998,633
+$38,733,089 QoQ
Shares Held
3,592,740
+157.7% QoQ
Ownership
3.17%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#10
of 215 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Deep Track Capital, LP holds $5,341,997,223 across 58 Biotechnology names. VRDN ranks #29 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IMVT
Immunovant, Inc.
 9,341,151 $359,914,548
2 GPCR
Structure Therapeutics Inc.
 4,740,072 $254,399,664
3 PCVX
Vaxcyte, Inc.
 4,300,000 $249,959,000
4 ALNY
Alnylam Pharmaceuticals, Inc.
 825,000 $248,349,750
5 MANE
Veradermics, Inc
 2,000,000 $245,880,000
6 TARS
Tarsus Pharmaceuticals, Inc.
 3,666,768 $230,786,377
7 OCUL
Ocular Therapeutix, Inc
 19,686,282 $193,319,289
8 BMRN
Biomarin Pharmaceutical Inc
 3,307,481 $189,254,062

All Filings in VRDN

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $65,998,633 3,592,740
2026-03-31 $27,265,544 1,393,944
2025-12-31 $78,572,802 2,524,833
2025-09-30 $116,110,089 5,380,449
2025-06-30 $75,218,677 5,380,449
2025-03-31 $72,528,452 5,380,449
2024-12-31 $86,700,944 4,522,741
2024-09-30 $85,333,998 3,750,945
2024-06-30 $51,049,275 3,923,849
2024-03-31 $60,515,488 3,456,053
2023-12-31 $79,099,035 3,631,728
2023-09-30 $45,456,515 2,963,267
2023-06-30 $30,439,352 1,279,502
2023-03-31 $31,297,788 1,230,259
2022-12-31 $51,735,408 1,771,154
2022-09-30 $40,410,647 1,970,290
2022-06-30 $13,540,255 1,170,290
2022-03-31 $21,638,662 1,170,290
2021-12-31 $26,426,361 1,336,690